Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimorazole plus radiotherapy versus placebo plus radiotherapy in locally advanced head and neck squamous cell carcinoma
2013-002466-39Phase 3Unknown
- Sponsor
- The Christie
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in head and neck squamous cell carcinoma (HNSCC) comparing Nimorazole plus radiotherapy with Placebo plus radiotherapy (2 arms). Primary endpoint: Locoregional control without additional serious toxicity. Status: unknown.
02
Drugs
nimorazole
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2013-002466-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002466-39.